News
"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
In the Phase 2 study of patients with chronic kidney disease, the highest dose of the drug lowered by 86% the levels of ...
The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for ...
WASHINGTON — Robert F. Kennedy Jr. clinched the political support needed to become the nation’s top health official by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results